Surviving Cardiac Arrest May Depend on Where You Live

Conventional Medicine Ignores the Science behind Preventing Sudden Cardiac Death with Fish Oil The U.S. has waged a five-decade war on heart disease thanks to the information gleaned  from the Framingham Study and the studies that followed it. That war has been dominated by the use of prescription drugs, surgery, and procedures that include angioplasty… Continue reading Surviving Cardiac Arrest May Depend on Where You Live

Nutrition Business Journal’s CAM Report Offers Detailed Analysis on the $39.5 Billion Complementary Alternative Medicine Services Market

Research and Markets has coverage of the Nutrition Business Journal’s “Complementary and Alternative Medicine and Practitioner Supplement Sales Report 2007.” The CAM Report 2007 presents detailed analysis on the $39.5 billion (yes, that’s “billion” with a B) complementary and alternative medicine services market and $1.7 billion practitioner channel supplement market in the U.S.

Hyperbaric Oxygen for Our Nation’s Veterans

Report from the Trenches:  Government Affairs from your Nation’s Capitol Dr. William A. Duncan, Your Lobbyist in Washington The DoD-Brain Injury Rescue & Rehabilitation Project Since January of 2007, the American Association for Health Freedom has sponsored a project to have veterans of the war treated with Hyperbaric Oxygen Therapy (HBOT).  Thank you to the… Continue reading Hyperbaric Oxygen for Our Nation’s Veterans

Survey Shows Integrative Medicine on Rise with Practitioners

To no surprise to AAHF, as more and more consumers are embracing integrative medicine, so are practitioners.  According to a recent survey by Jackson & Coker, a significant number of healthcare providers are using some form of integrative medicine to enhance their own health and well-being, or they have introduced certain facets of alternative medicine… Continue reading Survey Shows Integrative Medicine on Rise with Practitioners

FDA’s Stealth Attack on Chelation Therapy for Cardio-Vascular Disease

The Food and Drug Administration (FDA) recently released a Public Health Advisory on Edetate Disodium (EDTA).  The advisory reflects FDA’s current analysis of data available concerning this drug.  The advisory is meant to alert patients and healthcare professionals about EDTA.